3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Spinal Cord Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Leukemia
1
Hepatic Veno-Occlusive Disease
1
Glioma
1
Endometrial Hyperplasia
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Interventions
Gonadotropin-Releasing Hormone
2
xinmailong
1
palbociclib
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vitamin B 6
1
Vitamin B 12
1
Testosterone
1
Rivaroxaban
1
Progesterone
1
Genetic Testing
1
Folic Acid
1
Estradiol
1
DNA
1
Cardiovascular Agents
1
Blood Specimen Collection
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Cardiovascular Diseases
×
Genetic Testing
×
Clear all
NCT02485626
2016-10-31
HARBOR
The Netherlands Cancer Institute
Unknown
628 enrolled